Login / Signup
Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Vijayashree Priyadharsini Jayaseelan
Arumugam Paramasivam
Published in:
Future oncology (London, England) (2022)
Keyphrases
</>
combination therapy
cell proliferation
open label
anti inflammatory
randomized controlled trial